211 related articles for article (PubMed ID: 21143560)
41. 15-Deoxy-Delta(12,14)-prostaglandin J(2) stabilizes, but functionally inactivates p53 by binding to the cysteine 277 residue.
Kim DH; Kim EH; Na HK; Sun Y; Surh YJ
Oncogene; 2010 Apr; 29(17):2560-76. PubMed ID: 20208557
[TBL] [Abstract][Full Text] [Related]
42. The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J2 binds to and activates H-Ras.
Oliva JL; Pérez-Sala D; Castrillo A; Martínez N; Cañada FJ; Boscá L; Rojas JM
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4772-7. PubMed ID: 12684535
[TBL] [Abstract][Full Text] [Related]
43. Identification of the interactive interface and phylogenic conservation of the Nrf2-Keap1 system.
Kobayashi M; Itoh K; Suzuki T; Osanai H; Nishikawa K; Katoh Y; Takagi Y; Yamamoto M
Genes Cells; 2002 Aug; 7(8):807-20. PubMed ID: 12167159
[TBL] [Abstract][Full Text] [Related]
44. An endogenous electrophile that modulates the regulatory mechanism of protein turnover: inhibitory effects of 15-deoxy-Delta 12,14-prostaglandin J2 on proteasome.
Shibata T; Yamada T; Kondo M; Tanahashi N; Tanaka K; Nakamura H; Masutani H; Yodoi J; Uchida K
Biochemistry; 2003 Dec; 42(47):13960-8. PubMed ID: 14636064
[TBL] [Abstract][Full Text] [Related]
45. Structural requirements of cyclopentenone prostaglandins to induce endothelial cell apoptosis.
Vosseler CA; Erl W; Weber PC
Biochem Biophys Res Commun; 2003 Jul; 307(2):322-6. PubMed ID: 12859958
[TBL] [Abstract][Full Text] [Related]
46. 15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes.
Shibata T; Kondo M; Osawa T; Shibata N; Kobayashi M; Uchida K
J Biol Chem; 2002 Mar; 277(12):10459-66. PubMed ID: 11786541
[TBL] [Abstract][Full Text] [Related]
47. 15-deoxy-Δ12,14-prostaglandin J₂ induces p53 expression through Nrf2-mediated upregulation of heme oxygenase-1 in human breast cancer cells.
Kim DH; Song NY; Kim EH; Na HK; Joe Y; Chung HT; Surh YJ
Free Radic Res; 2014 Sep; 48(9):1018-27. PubMed ID: 24568186
[TBL] [Abstract][Full Text] [Related]
48. Role of 15-deoxy delta(12,14) prostaglandin J2 and Nrf2 pathways in protection against acute lung injury.
Mochizuki M; Ishii Y; Itoh K; Iizuka T; Morishima Y; Kimura T; Kiwamoto T; Matsuno Y; Hegab AE; Nomura A; Sakamoto T; Uchida K; Yamamoto M; Sekizawa K
Am J Respir Crit Care Med; 2005 Jun; 171(11):1260-6. PubMed ID: 15750045
[TBL] [Abstract][Full Text] [Related]
49. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.
Straus DS; Pascual G; Li M; Welch JS; Ricote M; Hsiang CH; Sengchanthalangsy LL; Ghosh G; Glass CK
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4844-9. PubMed ID: 10781090
[TBL] [Abstract][Full Text] [Related]
50. Contribution of covalent protein modification to the antiinflammatory effects of cyclopentenone prostaglandins.
Pérez-Sala D; Cernuda-Morollón E; Pineda-Molina E; Cañada FJ
Ann N Y Acad Sci; 2002 Nov; 973():533-6. PubMed ID: 12485923
[TBL] [Abstract][Full Text] [Related]
51. Thioredoxin as a molecular target of cyclopentenone prostaglandins.
Shibata T; Yamada T; Ishii T; Kumazawa S; Nakamura H; Masutani H; Yodoi J; Uchida K
J Biol Chem; 2003 Jul; 278(28):26046-54. PubMed ID: 12709421
[TBL] [Abstract][Full Text] [Related]
52. Thiol antioxidant and thiol-reducing agents attenuate 15-deoxy-delta 12,14-prostaglandin J2-induced heme oxygenase-1 expression.
Liu JD; Tsai SH; Lin SY; Ho YS; Hung LF; Pan S; Ho FM; Lin CM; Liang YC
Life Sci; 2004 Mar; 74(19):2451-63. PubMed ID: 14998722
[TBL] [Abstract][Full Text] [Related]
53. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress.
Zhang DD; Hannink M
Mol Cell Biol; 2003 Nov; 23(22):8137-51. PubMed ID: 14585973
[TBL] [Abstract][Full Text] [Related]
54. Role of heme oxygenase-1 protein in the neuroprotective effects of cyclopentenone prostaglandin derivatives under oxidative stress.
Satoh T; Baba M; Nakatsuka D; Ishikawa Y; Aburatani H; Furuta K; Ishikawa T; Hatanaka H; Suzuki M; Watanabe Y
Eur J Neurosci; 2003 Jun; 17(11):2249-55. PubMed ID: 12814358
[TBL] [Abstract][Full Text] [Related]
55. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers.
Wakabayashi N; Dinkova-Kostova AT; Holtzclaw WD; Kang MI; Kobayashi A; Yamamoto M; Kensler TW; Talalay P
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2040-5. PubMed ID: 14764894
[TBL] [Abstract][Full Text] [Related]
56. Discovery of the negative regulator of Nrf2, Keap1: a historical overview.
Itoh K; Mimura J; Yamamoto M
Antioxid Redox Signal; 2010 Dec; 13(11):1665-78. PubMed ID: 20446768
[TBL] [Abstract][Full Text] [Related]
57. Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in human mesangial cells.
Zhang X; Lu L; Dixon C; Wilmer W; Song H; Chen X; Rovin BH
Kidney Int; 2004 Mar; 65(3):798-810. PubMed ID: 14871400
[TBL] [Abstract][Full Text] [Related]
58. 15-Deoxy-prostaglandin J2 anti-inflammation in a rat model of chronic obstructive pulmonary disease and human bronchial epithelial cells via Nrf2 activation.
Li XY; Luo BL; Wang LJ; Zhang WD; Liu ZG
Genet Mol Res; 2015 Oct; 14(4):14037-42. PubMed ID: 26535717
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
60. Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages.
Kim HY; Kim HS
Immunol Cell Biol; 2007 Jan; 85(1):60-7. PubMed ID: 17130903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
